Webinar to be held on Friday, October 27, 2023 from 12:30 pm - 1:45 pm Eastern Time
Genprex’s lead drug candidate, REQORSA™ Immunogene Therapy that uses our proprietary, non-viral ONCOPREX® Nanoparticle Delivery System was highlighted in a Key Opinion Leader event hosted by Alliance Global Partners (AGP) for their institutional customers.
Designed and Secured by Barsec